These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 39414931)

  • 1. Integrated multicenter deep learning system for prognostic prediction in bladder cancer.
    He Q; Xiao B; Tan Y; Wang J; Tan H; Peng C; Liang B; Cao Y; Xiao M
    NPJ Precis Oncol; 2024 Oct; 8(1):233. PubMed ID: 39414931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and validation of a prognostic immune-related lncRNA signature in bladder cancer.
    Zhao K; Zhang Q; Zeng T; Zhang J; Song N; Wang Z
    Transl Androl Urol; 2021 Mar; 10(3):1229-1240. PubMed ID: 33850758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-omics reveals novel prognostic implication of SRC protein expression in bladder cancer and its correlation with immunotherapy response.
    Xu W; Anwaier A; Ma C; Liu W; Tian X; Palihati M; Hu X; Qu Y; Zhang H; Ye D
    Ann Med; 2021 Dec; 53(1):596-610. PubMed ID: 33830879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep learning signature based on multiphase enhanced CT for bladder cancer recurrence prediction: a multi-center study.
    Wang H; Zhang M; Miao J; Hou F; Chen Y; Huang Y; Yang L; Yang S; Huang C; Song Y; Niu H
    EClinicalMedicine; 2023 Dec; 66():102352. PubMed ID: 38094161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From slides to insights: Harnessing deep learning for prognostic survival prediction in human colorectal cancer histology.
    Verma J; Sandhu A; Popli R; Kumar R; Khullar V; Kansal I; Sharma A; Garg K; Kashyap N; Aurangzeb K
    Open Life Sci; 2023; 18(1):20220777. PubMed ID: 38152577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. End-to-end prognostication in colorectal cancer by deep learning: a retrospective, multicentre study.
    Jiang X; Hoffmeister M; Brenner H; Muti HS; Yuan T; Foersch S; West NP; Brobeil A; Jonnagaddala J; Hawkins N; Ward RL; Brinker TJ; Saldanha OL; Ke J; Müller W; Grabsch HI; Quirke P; Truhn D; Kather JN
    Lancet Digit Health; 2024 Jan; 6(1):e33-e43. PubMed ID: 38123254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-task deep learning-based radiomic nomogram for prognostic prediction in locoregionally advanced nasopharyngeal carcinoma.
    Gu B; Meng M; Xu M; Feng DD; Bi L; Kim J; Song S
    Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):3996-4009. PubMed ID: 37596343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome and Biomarker Supervised Deep Learning for Survival Prediction in Two Multicenter Breast Cancer Series.
    Bychkov D; Joensuu H; Nordling S; Tiulpin A; Kücükel H; Lundin M; Sihto H; Isola J; Lehtimäki T; Kellokumpu-Lehtinen PL; von Smitten K; Lundin J; Linder N
    J Pathol Inform; 2022; 13():9. PubMed ID: 35136676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical use of machine learning-based pathomics signature for diagnosis and survival prediction of bladder cancer.
    Chen S; Jiang L; Zheng X; Shao J; Wang T; Zhang E; Gao F; Wang X; Zheng J
    Cancer Sci; 2021 Jul; 112(7):2905-2914. PubMed ID: 33931925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Validation of a Six-Gene Prognostic Signature for Bladder Cancer.
    Xu F; Tang Q; Wang Y; Wang G; Qian K; Ju L; Xiao Y
    Front Genet; 2021; 12():758612. PubMed ID: 34938313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of necroptosis-related long non-coding RNAs prognostic signature and the crucial lncRNA in bladder cancer.
    Sun YF; Chen L; Xia QJ; Wang TH
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10217-10234. PubMed ID: 37269345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An innovative model based on N7-methylguanosine-related lncRNAs for forecasting prognosis and tumor immune landscape in bladder cancer.
    Ren L; Yang X; Liu J; Wang W; Liu Z; Lin Q; Huang B; Pan J; Mao X
    Cancer Cell Int; 2023 May; 23(1):85. PubMed ID: 37158958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitination-Related Molecular Subtypes and a Novel Prognostic Index for Bladder Cancer Patients.
    Cai H; Chen H; Huang Q; Zhu JM; Ke ZB; Lin YZ; Zheng QS; Wei Y; Xu N; Xue XY
    Pathol Oncol Res; 2021; 27():1609941. PubMed ID: 34776794
    [No Abstract]   [Full Text] [Related]  

  • 14. The impact of previous cancer on overall survival of bladder cancer patients and the establishment of nomogram for overall survival prediction.
    Wang Z; Zhou Y; Guan C; Ding Y; Tao S; Huang X; Chen L; Zhang F; Zhang R
    Medicine (Baltimore); 2020 Sep; 99(38):e22191. PubMed ID: 32957347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Analysis of Differentially Expressed DNA Damage Repair Genes in Bladder Cancer.
    Yang Y; Yu J; Xiong Y; Xiao J; Dai D; Zhang F
    Pathol Oncol Res; 2022; 28():1610267. PubMed ID: 35685866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A panel of eight-miRNA signature as a potential biomarker for predicting survival in bladder cancer.
    Zhou H; Tang K; Xiao H; Zeng J; Guan W; Guo X; Xu H; Ye Z
    J Exp Clin Cancer Res; 2015 May; 34(1):53. PubMed ID: 25991007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep Learning for Fully Automated Prediction of Overall Survival in Patients Undergoing Resection for Pancreatic Cancer: A Retrospective Multicenter Study.
    Yao J; Cao K; Hou Y; Zhou J; Xia Y; Nogues I; Song Q; Jiang H; Ye X; Lu J; Jin G; Lu H; Xie C; Zhang R; Xiao J; Liu Z; Gao F; Qi Y; Li X; Zheng Y; Lu L; Shi Y; Zhang L
    Ann Surg; 2023 Jul; 278(1):e68-e79. PubMed ID: 35781511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep learning radiomics analysis based on computed tomography for survival prediction in gastric neuroendocrine neoplasm: a multicenter study.
    Yang Z; Han Y; Li F; Zhang A; Cheng M; Gao J
    Quant Imaging Med Surg; 2023 Dec; 13(12):8190-8203. PubMed ID: 38106311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Nomogram Based on Machine Learning-Pathomics Signature and Neutrophil to Lymphocyte Ratio for Survival Prediction of Bladder Cancer Patients.
    Chen S; Jiang L; Zhang E; Hu S; Wang T; Gao F; Zhang N; Wang X; Zheng J
    Front Oncol; 2021; 11():703033. PubMed ID: 34222026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accurate Diagnosis and Survival Prediction of Bladder Cancer Using Deep Learning on Histological Slides.
    Zheng Q; Yang R; Ni X; Yang S; Xiong L; Yan D; Xia L; Yuan J; Wang J; Jiao P; Wu J; Hao Y; Wang J; Guo L; Jiang Z; Wang L; Chen Z; Liu X
    Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.